Skip to content

CYPH CYPH Increase Decrease In Research And Development Incentive Receivable

Increase Decrease In Research And Development Incentive Receivable at other companies

Replimune Group logo
Replimune GroupREPL
-$1.63M-473%
VAN
Vivani MedicalVANI
$43K+155%
PVL
Palvella TherapeuticsPVLA
-$526.25K-206%
Replimune Group logo
Replimune GroupREPL
$2.96M-3.6%
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
-$59.17K+99.4%
Altimmune logo
AltimmuneALT
-$518K+60.1%

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-54.5%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept cyph:IncreaseDecreaseInResearchAndDevelopmentIncentiveReceivable.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's increase decrease in research and development incentive receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's increase decrease in research and development incentive receivable?
CYPH (CYPH) reported increase decrease in research and development incentive receivable of $55K in Q1 2025.
What does increase decrease in research and development incentive receivable mean?
Measures the net change in receivables related to government grants, tax credits, or other incentives specifically tied to research and development activities. An increase indicates that the company has accrued more credits than it has collected, while a decrease reflects the realization of these incentives as cash. It provides insight into the company's ability to leverage external funding for innovation.